David J. Horin

2017 - Array BioPharma

In 2017, David J. Horin earned a total compensation of $83K as Interim Chief Financial Officer at Array BioPharma, a 59% decrease compared to previous year.

Compensation breakdown

Other$82,950
Total$82,950

Horin received $83K in other compensation, accounting for 100% of the total pay in 2017.

Rankings

In 2017, David J. Horin's compensation ranked 14,474th out of 14,666 executives tracked by ExecPay. In other words, Horin earned more than 1.3% of executives.

ClassificationRankingPercentile
All
14,474
out of 14,666
1st
Division
Manufacturing
5,696
out of 5,772
1st
Major group
Chemicals And Allied Products
2,049
out of 2,075
1st
Industry group
Drugs
1,705
out of 1,731
2nd
Industry
Pharmaceutical Preparations
1,314
out of 1,333
1st
Source: SEC filing on September 13, 2017.

Horin's colleagues

We found five more compensation records of executives who worked with David J. Horin at Array BioPharma in 2017.

2017

Ron Squarer

Array BioPharma

Chief Executive Officer

2017

Andrew Robbins

Array BioPharma

Chief Operating Officer

2017

Victor Sandor

Array BioPharma

Chief Medical Officer

2017

Jason Haddock

Array BioPharma

Chief Financial Officer

2017

John Moore

Array BioPharma

General Counsel

You may also like